[1]
D. . Gospodinov, L. . Hadzhiilieva, and N. . Gerasimov, “Incretin axis in cardiometabolic disease: molecular and systemic mechanisms of GLP-1 and GIP therapies”, MR, vol. 62, no. 5, pp. 5–11, Sep. 2026, Accessed: Sep. 14, 2026. [Online]. Available: https://journals.mu-sofia.bg/index.php/mr/article/view/1128